Timothy T. Goodnow

Timothy T. Goodnow

Chief Executive Officer presso SENSEONICS HOLDINGS, INC.

Patrimonio netto: 4 M $ in data 31/03/2024

62 anni
Health Technology
Electronic Technology
Commercial Services

Profilo

Timothy T.
Goodnow
is the President, Chief Executive Officer & Director of Senseonics Holdings, Inc. since 2015.
Prior to this, he was the President, Chief Executive Officer & Director of Senseonics, Inc. from 2011 to 2015.
He was also the Vice President-Technical Operations at Abbott Diabetes Care, Inc. from 2000 to 2011 and the Vice President-Research & Development at TheraSense, Inc. He worked as a Principal at Baxter Healthcare Corp., Verax Biomedical, Inc., and Dade Behring, Inc. Dr. Goodnow received his undergraduate and doctorate degrees from the University of Miami.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/11/2023 7 708 290 ( 1.45% ) 4 M $ 31/03/2024

Posizioni attive di Timothy T. Goodnow

SocietàPosizioneInizio
SENSEONICS HOLDINGS, INC. Chief Executive Officer 01/12/2015
Tutte le posizioni attive di Timothy T. Goodnow

Precedenti posizioni note di Timothy T. Goodnow

SocietàPosizioneFine
Chief Executive Officer 01/12/2015
Chief Tech/Sci/R&D Officer 01/02/2011
Chief Tech/Sci/R&D Officer 06/04/2004
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Timothy T. Goodnow

Formazione di Timothy T. Goodnow

University of Miami Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Timothy T. Goodnow

Relazioni

37

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
SENSEONICS HOLDINGS, INC.

Electronic Technology

Aziende private6

Health Technology

Health Technology

Commercial Services

Electronic Technology

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Timothy T. Goodnow